Michael Aaron Kelly
CIK 1769668 · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.47M
Companies
6
Total Filings
37
Lifetime Open-Market Net
$38.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRME | Director | — | $3.04 | — | $0 | 6 | 2026-06-08 |
| NEO | Director | 72,086 | $15.46 | $1.11M | $38.0K | 9 | 2026-06-03 |
| BOOM | Director | 65,590 | $5.41 | $354.8K | $0 | 8 | 2026-05-14 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 0 | $14.49 | $0 | $0 | 7 | 2026-04-27 |
| HOOKIPA Pharma Inc. (HOOK) Delisted | Director | 575 | $1.15 | $661 | $0 | 5 | 2022-07-01 |
| APRE | Director | 230 | $0.64 | $147 | $0 | 2 | 2021-07-01 |
Recent Filings · Page 2 of 4
37 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-27 | BOOM | Grant (A) | +5,518 | $0 | EDGAR |
| 2024-08-13 | NEO | Exer (M) | +11,336 | $0 | EDGAR |
| 2024-06-14 | PRME | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +11,847 | $0 | EDGAR |
| 2024-06-04 | NEO | Grant (A) | — | $0 | EDGAR |
| 2024-05-15 | BOOM | Grant (A) | +9,520 | $0 | EDGAR |
| 2023-08-14 | NEO | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | PRME | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +8,584 | $0 | EDGAR |
| 2023-05-10 | BOOM | Grant (A) | +7,086 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.